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Abstract Obsessive–compulsive disorder (OCD) is char-
acterized by recurrent, intrusive and disturbing thoughts as
well as by repetitive stereotypic behaviors. Epidemiological
data are similar in children and adults, i.e., between 1 and 3%
of the general population suffer from OCD. Children with
OCD are often seriously impaired in their development. OCD,
especially of early onset, has been shown to be familial.
Several candidate genes of predominantly neurotransmitter
systems have been analyzed and a total of three genome-wide
linkage scans have been performed until now. Analyses of
candidate genes in linkage regions have not provided evidence
for their involvement in OCD, with the exception of the glu-
tamate transporter gene SLC1A1 on 9p24. Genome-wide
association analyses are in progress and the results will pro-
mote further independent replication studies. The consider-
ation of subtypes regarding age of onset, symptom dimensions
and/or comorbid disorders is needed.
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Introduction
Obsessive–compulsive disorder (OCD) is a heterogeneous
psychiatric disorder characterized by clinically significant
recurrent, intrusive and disturbing thoughts (obsessions) as
well as by repetitive stereotypic behaviors, which are
usually associated with anxiety or dread (compulsions).
OCD affects up to 3% of the population and an early age of
symptom onset has been observed in many patients [18, 38,
49]. According to the National Comorbidity Survey Rep-
lication, OCD has a median age at onset of 19 years, with
21% of all cases starting by the age of 10 years [27].
Furthermore, OCD often follows a chronic course and has a
poor long-term prognosis. Pooled mean persistence rates
were 41% for full OCD and 60% for full or subthreshold
OCD [48]. Kessler et al. [27] have found OCD to be the
anxiety disorder with the highest percentage (50%) of
serious cases. Converging evidence from various lines of
research supports a causal role of the cortico-basal ganglia-
thalamo-cortical loops that involve the orbitofrontal cortex
and the anterior cingulate cortex. A review of the neuro-
biology of OCD is given by Grados and Wilcox [19] in
their research update of genetics in OCD.
Formal genetic findings
Twin and family studies have led to a better understanding
of the contribution of both genetic and environmental
factors to the development of OCD. Knowledge of the
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formal genetic aspects of OCD is a prerequisite for the
understanding of the results of numerous molecular genetic
studies.
Twin studies
There are only a very limited number of twin studies
regarding early-onset OCD and OC symptoms (see
Table 1). In a study of anxiety-related behaviors, Eley et al.
[15] observed a heritability of OC behavior of 0.65 in 4,564
preschool twins. Hudziak et al. [26] studied the Child
Behaviour Checklist Obsessive Compulsive Scale (CBCL-
OCS) in a sample of the Netherlands Twins Registry
(NTR) and in a second sample of the Missouri Twin Study.
In the NTR sample, the authors assessed twin pairs, whose
parents reported on their behavior via CBCL when they
were 7, 10 or 12 years of age. A total of 4,246, 2,841 and
1,562 twin pairs were available for analysis at ages 7, 10
and 12 years, respectively. The 10- and 12-year-old sam-
ples were subsets of the 7-year-old sample. In the Missouri
Twin Study sample, the twins were aged 8.8–9.5 years. A
total of 1,461 twin pairs were available for the analysis of
CBCL-OCS. Analysis of the twin correlations yielded
evidence for the influence of both genetic and environ-
mental factors. Across age groups and the two cultures
(Netherlands and USA), the additive genetic influence on
the CBCL-OCS varied from 45 to 58%. The variance
accounted for by non-shared environmental factors ranged
from 42 to 55%. Only in the 12-year-old group of the NTR
sample, the magnitude of the shared environmental influ-
ences was about 16%.
Based on DSM-IV criteria, Bolton et al. [10] recently
investigated a community sample of 854 6-year-old twins
(see Table 1), whose mothers were interviewed after
positive screening at age 4 using a maternal-informant
composite questionnaire on anxiety related behaviors and
tics. The study aimed to address whether individual dif-
ferences in early-onset OCD, tics and anxiety disorders
show familial aggregation effects due to either genetic or
environmental influences. For the final analysis, a child
was assigned a ‘‘symptom syndrome’’ on meeting the full
DSM-IV symptom criteria for the disorder regardless of the
degree of impairment, defined by the interview schedule
rules [Anxiety Disorders Interview Schedule for Children
and Parents (ADIS-C/P)]. To maximize the numbers, a
phenotype termed ‘‘subthreshold for symptom syndrome’’
was also included (for more details see Bolton et al. [10].
Additive genetic effects accounted for 29% of the variance
of the OCD phenotype including subthreshold cases. The
estimation of familial effects due to both combined addi-
tive genetic effects and shared environmental factors,
which could not be distinguished in this study, was 47%. In
this pediatric population, significant within-twin associa-
tions between OCD and tics as well as OCD and anxiety
disorders were observed.
A review of the findings based on twin studies of chil-
dren and adults was compiled by Van Grootheest et al.
[50]. The authors concluded that the heritability for
obsessive–compulsive symptoms ranges from 0.45 to 0.65
in children and from 0.27 to 0.47 in adults.
Family studies
First-degree relatives of patients with OCD have elevated
rates of OCD as well as anxiety, mood, attention deficit/
hyperactivity and tic disorders. In earlier studies, family
members were not investigated using standardized inter-
views. Familial rates were described using the family his-
tory method with one person (the index patient) or, in the
case of children, with the mother or father providing
Table 1 Twin studies of early-onset OCD or OC symptoms
Number of twins Age at investigation (years) Heritability Instruments Studies
4,564 4 0.65 for OC
behavior
Mother-reported
anxiety-related
behaviors
Eley et al. [15]
4,246a 7a 0.45–0.58 CBCL-OCSb Hudziak et al. [26]
2,841a 10a
1,562a 12a
1,461c 8.8–9.5c
854 6 0.47 for
subthreshold OCD
DSM-IV
ADIS-C/Pd
Bolton et al. [10]
a The Netherlands sample was divided into three age groups
b CBCL-OCS: Child Behaviour Checklist Obsessive–Compulsive Scale
c Missouri Twin study, average age of 9 years
d Anxiety disorders interview schedule for children and parents
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information about all first-degree relatives. Although this
kind of assessment probably underestimated the rate of
affected relatives, the findings suggested that OCD was
familial. Since the 1980s, direct interview studies have
been performed, investigating as many first- and second-
degree family members as possible. Family studies showed
that first-degree relatives of patients with OCD were
affected by OCD considerably more frequently than rela-
tives of healthy control subjects (see Table 2).
Family studies based on children and adolescents with
OCD
Among the parents of children with severe OCD, Lenane
et al. [30] detected OCD in 25% of the fathers and in 9% of
the mothers. Riddle et al. [45] reported that 15 out of 21
(71%) OCD children had a parent with either OCD (N = 4)
or obsessive–compulsive symptoms (N = 11). Chabane
et al. [11] did not find elevated rates of OCD among family
members of patients with an age of onset of [16 years.
These authors concluded that some children with OCD
may show a high degree of familiality, while a consider-
able number show no familiality. Hanna et al. [21] exam-
ined first- and second-degree relatives of 35 children with
OCD and of 17 healthy controls. The lifetime prevalences
of definite OCD were significantly higher in first-degree
relatives than in control relatives (22.5% vs. 2.6%; ratio:
8.65). The difference between case and control first-degree
relatives increased on inclusion of subthreshold OCD
(27.4% vs. 2.6%), yielding a relative risk of 10.54. In
contrast to these findings based on first-degree relatives,
there were no significant differences between case and
control second-degree relatives. This study, however,
probably underestimated the true rate of OCD in second-
degree relatives, since the majority of them were not
directly interviewed. According to the same study of Hanna
et al. [21], an increase in lifetime OCD and subthreshold
OCD was observed in relatives of patients with ordering
compulsions compared to the relatives of OCD patients
without these compulsions (45.4% vs. 18.8%). Furthermore
lifetime prevalence of definite OCD was significantly
higher in the case of first-degree relatives with a history of
tics than in the case of first-degree relatives without a tic
history (57.1% vs. 20.9%).
Among family studies based on children with OCD,
Rosario-Campos et al. [14] also reported a high rate of first-
degree relatives affected by OCD (22.7%). The average
age of the index patients was very low (onset less than
7 years) in comparison to the age of index patients in other
family studies (see Table 2). Moreover, the age of onset of
OCD in the index patients was correlated with that in the
affected first-degree relatives [14]. In this study, the
patients had high co-morbidity rates with Tourette syn-
drome (33%) and tic disorders (13.2%).
In contrast, an earlier study of Reddy et al. [44] reported
a prevalence rate of 4.96% in first-degree relatives of
Table 2 Familiality in children
and adults with OCD
a Studies performed in samples
ascertained through children
with OCD
b Subthreshold OCD using
DSM-III-R
c 82% of the patients had an
onset prior to 18 years of age
d Including subthreshold OCD
using DSM-IV
OCD in first-degree
relatives of index
patients with onset B18 years
(%)
OCD in first-degree
relatives of index
patients with onset
[18 years (%)
OCD in first-degree
relatives of
controls (%)
Studies
25 in mothers
9 in fathers
Lenane et al. [30]a
8.8 Bellodi et al. [7]
2.5 2.3 Black et al. [8]
4.9 Nicolini et al. [39]
19
52b
Riddle et al. [45]a
10.3
7.9b
1.9
2.0b
Pauls et al. [42]c
11.7 0 2.7 Nestadt et al. [38]
4.96 0 Reddy et al. [44]a
3.5 Albert et al. [1]
22.7
29.2d
0.9
2.4d
do Rosario-Campos
et al. [14]a
16.1 2.9 Chabane et al. [11]a
22.5
27.4d
2.6 Hanna et al. [21]a
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juvenile patients with OCD (aged 16 years or less), while
no OCD was observed among the relatives of controls. In
contrast to other studies, none of the siblings of the index
patients received a diagnosis of OCD and none of the first-
degree relatives had subthreshold OCD. The authors con-
cluded that most juvenile cases of OCD were non-familial
and unrelated to tic disorders. A limitation of this study
was the small sample size (35 patients and 34 age-matched
controls). Furthermore, the authors discussed that their
findings of a relatively low rate of OCD in the first-degree
relatives could be related to the only moderate clinical
symptomatology and the relatively short duration of the
illness in their index patients.
Family studies based on adults with childhood or
adolescent-onset OCD
Bellodi et al. [7] investigated families based on index
patients whose OCD commenced at different ages
(21 patients with age of onset of \14 years of age, and 71
patients with age of onset of[14 years of age). The risk for
OCD of all first-degree relatives was 3.4% and increased to
8.8% when patients had an onset of OCD earlier than
14 years of age. Pauls et al. [42] interviewed all available
first-degree relatives of 100 patients, whose OCD onset
was mainly in childhood and adolescence: 82 reported
onset of OCD symptoms at or before the age of 18 years.
OCD and subthreshold OCD were significantly more fre-
quent in the patients’ families in comparison to families of
healthy controls (10.3 and 7.9% and 1.9 and 2.0%,
respectively). The rate of OCD and subthreshold OCD was
approximately twice as high among the relatives of the
patients with early-onset as compared with the relatives of
patients with late-onset OCD (20.1% vs. 10.9%). It is of
note that most of this difference was due to the more
common occurrence of subthreshold OCD among the rel-
atives of the cases. Pauls et al. also found that first-degree
relatives of patients with OCD had higher frequencies of tic
disorders (4.6%) than relatives of the controls (1%). Nes-
tadt et al. [38] reported an OCD prevalence rate of 11.7%
in first-degree relatives of OCD patients and of 2.7% in
relatives of controls. There were no affected first-degree
relatives of patients with an OCD onset after the age of
17 years.
The comparatively high familiality in early versus late
OCD [1, 8, 39] is illustrated in Table 2 based on both
childhood and adult index patients. The wide range of
prevalence rates of OCD in first-degree relatives across
different studies merits discussion. Heterogeneity of the
phenotype, the absence of a control group, the young age of
siblings in studies of childhood OCD patients and too few
directly interviewed relatives may result in over/underes-
timation of the prevalence of OCD in relatives.
Investigators were in some studies not blinded with respect
to whether or not they were assessing relatives of cases or
controls or relatives of patients with early- versus late-
onset of OCD [7, 44, 45].
Molecular genetic findings in OCD
Linkage studies
Three genome-wide linkage studies of OCD have so far
been published. In two of these studies, the samples were
ascertained through patients with early-onset OCD
(\18 years of age, Hanna et al. [22, 23]). In all three
studies, no significant genome-wide evidence for linkage
was detected according to standard guidelines for linkage
studies [28]. However, several loci displayed suggestive
evidence for linkage and have provided valuable starting
points for follow-up association studies.
The first genome scan was performed by Hanna et al.
[22]. These authors analyzed 56 family members from
seven pedigrees, each ascertained via a child with OCD. Of
the relatives, 27 also had a lifetime diagnosis of OCD. As
much as 349 microsatellite markers were used (with an
average between-marker distance of 11.3 cM). The maxi-
mum multipoint LOD (logarithm of the odds) score was
found to be 2.25 on 9p24 (marker D9S288) using a dom-
inant model. Evidence for linkage to 9p24 was also sup-
ported by Willour et al. [58], who in order to replicate the
findings of Hanna et al. [22] genotyped 50 pedigrees based
on OCD index patients (42 sib pairs, 8 trios; altogether 193
subjects), using microsatellite markers spanning only the
9p24-region [58]. These authors found their strongest
results for two markers (D9S1792, D9S1813) located
within 0.5 cM of the initial marker D9S288 [22]. Although
the eight trio pedigrees were not informative for the linkage
analysis, they were included in the 9p24 association anal-
ysis, which identified two markers (D9S288 and
GATA62F03) with p-values of \0.05 (Willour et al. [58])
using the pedigree-disequilibrium test. It is noteworthy that
93% of the probands of this study had an early age of onset
(\16 years of age), which was comparable to that
(\14 years of age) in the sample of Hanna et al. [22].
Shugart et al. [46] studied a sample of 219 families (sib
pairs and extended families). Multipoint analysis uncov-
ered several suggestive linkage signals on chromosomes
3q27–28, 6q, 7p, 1q and 15q. Covariate linkage analyses
implicated a possible role of a gene variant(s) on chro-
mosome 1 in increasing the risk for an early-onset form of
OCD [46]. The authors differentiated between the broad
and narrow phenotypes and found linkage to 3q27–28
using the broad phenotype definition, which included def-
inite and probable cases of OCD. The 3q27–28 region
230 Eur Child Adolesc Psychiatry (2010) 19:227–235
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harbors, among others, the serotonergic genes HTR3C (5-
hydroxytryptamine [serotonin] receptor 3, family member
C), HTR3D and HTR3E. Hanna et al. [23] undertook
another genome-wide linkage scan based on a total of 121
subjects, who were ascertained through 26 independent
index patients with ‘‘early-onset’’ OCD (onset of OC
symptoms before the age of 18 years). The maximum
nonparametric log of odds (NLOD) score was 2.43 on
chromosome 10p15 (marker D10S1745). However, the
NLOD score on 10p15 decreased to 1.8 on inclusion of the
data of their first genome scan [22]. Family-based associ-
ation tests conducted with 35 SNPs in the 10p15 region
provided evidence for association and linkage disequilib-
rium with three adjacent single-nucleotide polymorphisms
(SNPs) in the 30 region of the adenosine deaminase acting
on RNA 3 gene (ADAR3). Interestingly, drosophila dele-
tion mutants lacking ADAR activity have been observed to
spend an inordinate amount of time in grooming through-
out their life span [40]. The second highest NLOD score
was 1.54 on chromosome 1 (at 126 cM), which was
approximately 45–50 cM proximal to the region 1q
implicated in the genome scan of Shugart et al. [46].
Association studies
As described above, linkage studies have implicated sev-
eral chromosomal regions, but the results have mostly been
inconsistent. Only SNPs in the glutamate transporter gene
SLC1A1 on 9p24 have been found to be associated with
OCD, as based on a linkage finding. Otherwise, association
studies have primarily focused on neurobiologically and
pharmacologically plausible candidate genes such as SERT
[SLC6A4], HTR1D, HTR2A, HTR2C, DRD4, DRD2,
SLC1A1, GRIN2B, GABBR1, COMT, MAOA, TPH1,
TPH2, BDNF, NTRK2, OLIG2 and MOG. Two reviews
including candidate gene studies have recently been pub-
lished by Pauls et al. [41] and Grados and Wilcox [19]. In
contrast to both these publications, the next paragraph will
focus on results based on children with OCD (see Table 3).
Serotonergic system
Selective serotonin re-uptake inhibitors block the serotonin
transporter (SERT) and represent the most effective phar-
macological treatment for OCD. Most association studies
in OCD have therefore investigated serotonergic genes.
The most frequently studied gene is SERT [SCL6A4] with
its functional polymorphism in the upstream region termed
5-HTTLPR, which involves an insertion (L-[long] allele)/
deletion (S-[short] allele) polymorphism. In comparison
with the S-allele, the L-allele has been reported to exert an
increased transcriptional activity and an increased basal re-
uptake of 5-HT in vitro [24, 31, 37]. The L-allele is
therefore referred to as the gain-of-function variant of the
serotonin transporter. Bloch et al. [9] reported a stratified
meta-analysis investigating whether mean age of the sam-
ple (child vs. adult), ethnicity (Caucasian/Asian) and study
design (case–control/family-based association studies)
moderated any association. These authors found a signifi-
cant association between the L-allele and OCD in family-
based association studies (OR = 1.31; 95% CI: 1.02–1.69)
and in studies involving Caucasian children (OR = 1.41;
95% CI: 1.00–1.99), which might point to its specificity in
early-onset OCD in Caucasians. In our own sample, we
found a trend toward an association between the L-allele
and early-onset OCD [53].
The 5-HTTLPR has been functionally refined by subdi-
viding L-alleles into the high-functioning LA-alleles and low-
functioning LG-alleles. When this new classification is used,
approximately 5–10% of L-alleles (depending on ethnicity)
are low functioning and need to be grouped with the S-alleles
for comparison purposes [25]. In our own sample of early-
onset OCD patients, we observed a significant overtransmis-
sion of the LA-allele to affected offspring in 104 trios
(p = 0.0054, OR = 2.06; Wendland et al. under review [57]).
Serotonin receptor subtypes
The so-called HTR2 family consists of G-protein coupled
receptors known as HTR2A and HTR2C. They are pri-
marily associated with phospholipase C, which catalyzes
the hydrolysis of phosphatidylinositol bisphosphate (PIP2)
and generates the second messenger molecules inositol
triphosphate 3 (IP3) that mobilizes calcium from intracel-
lular stores resulting in PKC activation and diacylglycerol
(which potentiates PKC activation). PKC regulates
numerous processes of cell function. For example, PKC
activation causes a reduction in 5HT uptake capacity by
phosphorylation and sequestration of 5HT transporter
proteins [3]. The HTR2 subcategories have a widespread
distribution in the brain [3].
Studies regarding association studies of the HTR2A
polymorphisms (13q14–q21) in early-onset OCD are rare. In
our sample of children and adolescents with OCD, we found
in a case–control study an association of the A-allele of the -
1438A/G (rs6311) locus with OCD [54]. These results
pointed in the same direction as those of Enoch et al. [16, 17].
These authors also described a correlation between the -
1438A-allele and a retrospectively determined early onset of
the disease [16, 17]. The results of these studies were more
pronounced in female patients [17, 54].
The novel brain-specific tryptophan hydroxylase-2
(TPH2), the rate-limiting enzyme in 5-HT synthesis in the
brain, was studied for association in OCD [35]. In this first
study of TPH2 in OCD, rs4570625 and rs4565946 were
significantly overtransmitted as a G–C haplotype in
Eur Child Adolesc Psychiatry (2010) 19:227–235 231
123
children and adolescents with OCD. Moreover, a trend
toward preferential transmission of the C-allele of
rs4565946 in affected offspring was found. The genotype
relative-risk estimate for homozygous C-allele carriers of
rs4565946 was 2.58 (95% CI: 0.98–6.82).
Dopaminergic system
Obsessive–compulsive disorder patients, who are non-
responders to SSRIs, sometimes show clinical
improvement following low-dose neuroleptic treatment,
suggesting a dopaminergic role in OCD and therefore
justifying the investigation of dopamine-related candidate
genes. Several studies analyzed the variable number of
tandem repeats (VNTR) of the dopamine-receptor D4
(DRD4) gene based on a 48-base pair repeat in exon III. In
early-onset OCD, the most commonly observed four-repeat
allele was found to be undertransmitted in trios, while no
significant finding was observed for the seven-repeat allele
[52]. Catecholamine-O-methyltransferase (COMT) is an
Table 3 Results of association studies and meta-analyses in early-onset OCD
Patient group, study design Gene SNP or
variant
Association Studies
Children/adolescents, case control 5-HT2A
-1438A/G
rs6311
Positive Walitza et al. [54]
Adults with early onseta, case control 5-HT2A
-1438A/G
rs6311
Positive Enoch et al. [16, 17]
Children/adolescents, family based 5-HTTLPR
L-allele
Only a trend Walitza et al. [53]
Meta-analysis adults and children, case
control and family based
5-HTTLPR
L-allele
Positive for Caucasian children and in
family-based studies
Bloch et al. [9]
Children/adolescents, family based 5-HTTLPR
LA-allele
Positive Wendland et al. under review
[57]
Children/adolescents, family based TPH2
rs4570625
rs4565946
Overtransmission Mossner et al. [35]
Children/adolescents, family based DRD4 VNTR
4-repeat allele
Undertransmission Walitza et al. [52]
Children/adolescents, family based COMT
Val158Met
rs4680
No association Walitza et al. [52]
164 triads including 38 children and adolescents BDNF
Val66Met
rs6265
Positive Hall et al. [20]
Children/adolescents, family based BDNF No association Mossner et al. [36]
138 adults and 19 children/adolescents,
family based
SLC1A1
rs301434
Positive Arnold et al. [6]
Children/adolescents, family based SLC1A1
rs3780412
rs301430
Overtransmission Dickel et al. [13]
Children/adolescents SLC1A1
rs3780412
rs2228622
haplotype including
rs12682807
rs20772657
rs3011430
Overtransmission to male offspring
Positive association
Stewart et al. [47]
a The patients retrospectively had predominately reported an early onset of OCD
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enzyme involved in the metabolism of dopamine and a key
modulator of dopaminergic neurotransmission. A G [ A
substitution in codon 158 of COMT (Val158Met, rs4680)
causes a three- to four-fold reduction of COMT activity
and has been extensively studied for its association with
OCD. We detected no evidence of transmission disequi-
librium for COMT in early-onset OCD [52]. Another study
of 261 adult patients with OCD (reported age at onset
range: 2–51 years, mean age at investigation: 17.8 years)
described an association of early-onset OCD and Met/Met
genotype of COMT in a symptom cluster termed ‘‘Obses-
sional/checking’’ according to the Yale-Brown Obsessive–
Compulsive Symptoms Checklist [33]. This symptom
cluster included sexual, religious, somatic and harm-related
obsessions as well as a variety of related compulsions (e.g.,
checking).
Glutamatergic system
The neuronal glutamate transporter gene (SLC1A1) on 9p24
is one of the few candidate genes for OCD that was inves-
tigated due to its localization within a linkage peak (see
above). The role of this glutamate transporter gene in OCD is
supported by the observation that the anti-glutamatergic drug
riluzole can be beneficial in the treatment of OCD [43] and by
the finding of elevated glutamate levels in the cerebrospinal
fluid of OCD patients [12]. Shortly before SLC1A1 was
proposed as a 9p24 positional candidate, Veenstra-Vander-
Weele [51] performed a mutation screen and family-based
association of SLC1A1 with primarily negative results. Five
years later, Arnold et al. [6] detected an association of several
markers spanning SLC1A1 with OCD in a sample of mostly
adults and Dickel et al. [13] in children and adolescents. The
association of SLC1A1 with OCD was corroborated at the
haplotype and single-marker level by three other studies [32,
47, 56]. It should be noted, however, that all of the five
positive SLC1A1 association studies in OCD used markers
that only partially overlapped, and the findings regarding
some of the few markers that were genotyped in more than
one study were not consistently replicated. This inconsis-
tency and the fact that the association described by Stewart
et al. [47] in children and Wendland et al. [56] in adults
pertains to haplotypes suggest that there are additional
functional and possibly causal variants within the SLC1A1
region for OCD. It should further be noted that SLC1A1 also
acts as a cysteine transporter and that transgenic mice with
the disrupted orthologous gene Slc1a1 display grooming
abnormalities with increasing age [4]. It is also noteworthy
that Arnold et al. [5] have reported an association of a
glutamatergic receptor gene (GRIN2B) with early-onset
OCD. Further studies of glutamatergic neurons and
SLC1A1, in particular, are therefore warranted in early- and
adult-onset OCD.
Neurotrophic factors and transcription factors
Brain-derived neurotrophic factor (BDNF) promotes neu-
ronal proliferation, regeneration and connectivity during
development and participates in the plasticity and mainte-
nance of neurons throughout adulthood. In addition, the
neurotrophic tyrosine kinase (Trk) receptor type 2
(NTRK2) is highly linked to the activation of BDNF. Of
special interest is the BDNF Val66Met (rs6265) polymor-
phism, since this substitution may either influence the
processing of the mature form or affect the interaction of
the secreted and extracellularly processed pre–pro form
with p75 NTR, thus modulating apoptotic signaling
through this alternate pathway. Hall et al. [20] studied a
number of four SNPs including Val66Met (rs 6165) spread
over a distance of 56 kb at the BDNF gene in 164 triads
with OCD. They described evidence of association for all
the markers. This finding is also of interest because the
sample included 38 cases of early-onset OCD. Only in the
group of early-onset OCD and in the total group, but not in
the group consisting only of late-onset OCD, significant
associations were observed. However, later studies did not
find an association between OCD and BNDF [2, 36, 55,
59].
Additional evidence for the possible involvement of
neurotrophic pathways stems from the association of two
SNPs in the 30 downstream region of NTRK2 (rs1017412
and rs7176429) with OCD (OR = 2.16 and 2.78, respec-
tively) [2].
The gene for oligodendrocyte lineage transcription fac-
tor 2 (OLIG2), located on 21q22.11, is an essential regu-
lator in the development of human cells that produce white
matter (myelin). In a family-based association study, three
SNPs (rs762178, rs1059004 and rs9653711) within OLIG2
were associated with OCD without Tourette syndrome
[47]. This finding awaits confirmation in future studies.
Conclusion
Like other psychiatric disorders, OCD is a complex dis-
order and its pathogenesis is most likely influenced by both
genetic and environmental factors. Ongoing genome-wide
association studies may shed new insight into the molec-
ular genetic etiology of OCD. Possible gene–environment
interactions include the moderation by a functional poly-
morphism of the risk for developing OCD following
exposure to a traumatic event or an effect of a functional
polymorphism on the development of a personality/neu-
rocognitive profile that may predispose a person to OCD
following environmental stress. An improved understand-
ing of the OCD phenotype and the underlying etiological
mechanisms may require novel approaches in the
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conceptualization of the disorder. These approaches
include (1) narrowing the phenotype to identify categori-
cally defined more homogeneous and mutually exclusive
subtypes of OCD, (2) considering OC symptom dimensions
as quantitative components of the more complex OCD
phenotype and (3) broadening the phenotype to include
other etiologically related conditions [34]. More elaborate
phenotyping including age at onset, disease severity and
dimensional measures [29] are therefore needed. Finally,
the definition of endophenotypes through neuropsycho-
logical, neurophysiological and neuroimaging studies may
contribute to the understanding of the genetic factors
underlying OCD.
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